108 related articles for article (PubMed ID: 12746945)
21. Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002.
Paull K; Covar R; Jain N; Gelfand EW; Spahn JD
Pediatr Pulmonol; 2005 Apr; 39(4):311-7. PubMed ID: 15678505
[TBL] [Abstract][Full Text] [Related]
22. Reference equation for maximal voluntary ventilation in children and adolescents.
Silva JC; Carvalho IE; Dal Corso S; Lanza FC
Pediatr Pulmonol; 2020 Feb; 55(2):426-432. PubMed ID: 31742910
[TBL] [Abstract][Full Text] [Related]
23. Validation of shuttle tests in children with cystic fibrosis.
Selvadurai HC; Cooper PJ; Meyers N; Blimkie CJ; Smith L; Mellis CM; Van Asperen PP
Pediatr Pulmonol; 2003 Feb; 35(2):133-8. PubMed ID: 12526075
[TBL] [Abstract][Full Text] [Related]
24. [Effect of intensive movement rehabilitation and breathing exercise on respiratory parameters in children with idiopathic stage-I scoliosis].
Zaba R
Przegl Lek; 2003; 60 Suppl 6():73-5. PubMed ID: 15106462
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
[TBL] [Abstract][Full Text] [Related]
26. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment.
Mentore K; Froh DK; de Lange EE; Brookeman JR; Paget-Brown AO; Altes TA
Acad Radiol; 2005 Nov; 12(11):1423-9. PubMed ID: 16253854
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive tension time index in relation to severity of disease in children with cystic fibrosis.
Hahn A; Ankermann T; Claass A; Mann M; Lindemann H; Neubauer BA
Pediatr Pulmonol; 2008 Oct; 43(10):973-81. PubMed ID: 18780334
[TBL] [Abstract][Full Text] [Related]
28. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
29. Lung function in 3-5-year-old children with cystic fibrosis.
Mayer OH; Jawad AF; McDonough J; Allen J
Pediatr Pulmonol; 2008 Dec; 43(12):1214-23. PubMed ID: 18991339
[TBL] [Abstract][Full Text] [Related]
30. Prediction of the maximal voluntary ventilation in healthy adult Chinese subjects.
Kor AC; Ong KC; Earnest A; Wang YT
Respirology; 2004 Mar; 9(1):76-80. PubMed ID: 14982606
[TBL] [Abstract][Full Text] [Related]
31. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
[TBL] [Abstract][Full Text] [Related]
32. Spirometric values and aerobic efficiency of children and adolescents with hearing loss.
Zebrowska A; Zwierzchowska A
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():443-7. PubMed ID: 17072075
[TBL] [Abstract][Full Text] [Related]
33. Utility of the breathing reserve index at the anaerobic threshold in determining ventilatory-limited exercise in adult cystic fibrosis patients.
Sexauer WP; Cheng HK; Fiel SB
Chest; 2003 Oct; 124(4):1469-75. PubMed ID: 14555581
[TBL] [Abstract][Full Text] [Related]
34. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
[TBL] [Abstract][Full Text] [Related]
35. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.
Aurora P; Gustafsson P; Bush A; Lindblad A; Oliver C; Wallis CE; Stocks J
Thorax; 2004 Dec; 59(12):1068-73. PubMed ID: 15563707
[TBL] [Abstract][Full Text] [Related]
36. [Diffusing capacity for carbon monoxide (T(LCO)) and oxygen saturation during exercise in patients with cystic fibrosis].
Chemery L; Fekete K; Guillot S; Roussey M; Desrues B; Dabadie A; Belleguic C; Deneuville E; Dassonville J
Arch Pediatr; 2004 Sep; 11(9):1060-6. PubMed ID: 15350995
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary function between 40 and 80 years of age.
Ostrowski S; Grzywa-Celińska A; Mieczkowska J; Rychlik M; Lachowska-Kotowska P; Lopatyński J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():127-33. PubMed ID: 16204786
[TBL] [Abstract][Full Text] [Related]
38. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?
Roche N; Dalmay F; Perez T; Kuntz C; Vergnenègre A; Neukirch F; Giordanella JP; Huchon G
Respir Med; 2008 Nov; 102(11):1568-74. PubMed ID: 18657959
[TBL] [Abstract][Full Text] [Related]
39. Energy cost of activity and exercise in children and adolescents with cystic fibrosis.
Johnson MR; Ferkol TW; Shepherd RW
J Cyst Fibros; 2006 Jan; 5(1):53-8. PubMed ID: 16360343
[TBL] [Abstract][Full Text] [Related]
40. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
